Suppr超能文献

生物医学期刊中科学论文的撰写、发表所涉及的伦理问题与困境。

Ethical aspects and dilemmas of preparing, writing and publishing of the scientific papers in the biomedical journals.

作者信息

Masic Izet

机构信息

Academy of medical sciences of Bosnia and Herzegovina. Sarajevo, Bosnia and Herzegovina.

出版信息

Acta Inform Med. 2012 Sep;20(3):141-8. doi: 10.5455/aim.2012.20.141-148.

Abstract

INTRODUCTION

In this paper author discussed about preparing and submitting manuscripts - scientific, research, professional papers, reviews and case reports. Author described it from the Editor's perspective, and specially talked about ethical aspects of authorship, conflict of interest, copyright, plagiarism and duplicate publication from the point of view of his experiences as Editor-in-Chief of several biomedical journals and Chief of Task Force of European Federation of Medical Informatics journals and member of Task Force of European Cardiology Society journals. The scientific process relies on trust and credibility. The scientific community demands high ethical standards to conduct biomedical research and to publish scientific contents. During the last decade, disclosure of conflicts of interest (COI ), (also called competing loyalties, competing interests or dual commitments), has been considered as a key element to guarantee the credibility of the scientific process. Biases in design, analysis and interpretation of studies may arise when authors or sponsors have vested interests. Therefore, COI should be made clear to the readers to facilitate their own judgment and interpretation of their relevance and potential implications.

RESULTS AND DISCUSSION

Authors are responsible to fully disclose potential COI . In October 2009 the ICMJE proposed an electronic "uniform" format for COI disclosure. Four main areas were addressed: authors´ associations with entities that supported the submitted manuscript (indefinite time frame), associations with commercial entities with potential interest in the general area of the manuscript (time frame 36 months), financial association of their spouse and children and, finally, non-financial associations potentially relevant to the submitted manuscript. Consumers of medical scholarship expect a reliable system of disclosure in which journals and authors make disclosures appropriately and consistently. There is a stigma surrounding the reporting of COI that should be progressively overcome. Further actions are required to increase awareness of the importance of COI disclosure and to promote policies aimed to enhance transparency in biomedical research. In this article author discuss about important ethical dilemmas in preparing, writing and publishing of scientific manuscripts in biomedical journals.

摘要

引言

在本文中,作者探讨了科学、研究、专业论文、综述及病例报告等稿件的准备与提交。作者从编辑的视角进行了阐述,并特别结合其担任几本生物医学期刊主编、欧洲医学信息学联合会期刊工作组组长以及欧洲心脏病学会期刊工作组成员的经验,谈论了作者身份、利益冲突、版权、抄袭及重复发表等方面的伦理问题。科学进程依赖于信任和可信度。科学界要求在开展生物医学研究及发表科学内容时遵循高伦理标准。在过去十年中,披露利益冲突(COI,也称为相互冲突的忠诚、相互冲突的利益或双重承诺)被视为保证科学进程可信度的关键要素。当作者或资助者存在既得利益时,研究的设计、分析和解释可能会出现偏差。因此,应向读者明确披露利益冲突,以便他们自行判断并解读其相关性及潜在影响。

结果与讨论

作者有责任充分披露潜在的利益冲突。2009年10月,国际医学期刊编辑委员会(ICMJE)提出了一种用于披露利益冲突的电子“统一”格式。涉及四个主要方面:作者与支持所提交稿件的实体的关联(无明确时间框架)、与稿件总体领域可能存在利益关系的商业实体的关联(时间框架为36个月)、其配偶和子女的财务关联,以及最后与所提交稿件可能相关的非财务关联。医学学术成果的消费者期望有一个可靠的披露系统,期刊和作者能以适当且一致的方式进行披露。围绕利益冲突报告存在一种污名,应逐步予以克服。需要采取进一步行动,以提高对利益冲突披露重要性的认识,并推动旨在提高生物医学研究透明度的政策。在本文中,作者讨论了生物医学期刊在准备、撰写和发表科学稿件过程中重要的伦理困境。

相似文献

引用本文的文献

5
The Pursuit of Originality Makes Us All the Same!对原创性的追求让我们变得千篇一律!
Contemp Clin Dent. 2019 Jan-Mar;10(1):1-2. doi: 10.4103/ccd.ccd_410_19.

本文引用的文献

3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验